Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2005 Oct;76(10):1348–1354. doi: 10.1136/jnnp.2004.047720

Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease?

P Visser 1, P Scheltens 1, F Verhey 1
PMCID: PMC1739362  PMID: 16170074

Abstract

Background: Drugs effective in Alzheimer-type dementia have been tested in subjects with mild cognitive impairment (MCI) because these are supposed to have Alzheimer's disease in the predementia stage.

Objectives: To investigate whether MCI criteria used in these drug trials can accurately diagnose subjects with predementia Alzheimer's disease.

Methods: MCI criteria of the Gal-Int 11 study, InDDEx study, ADCS memory impairment study, ampakine CX 516 study, piracetam study, and Merck rofecoxib study were applied retrospectively in a cohort of 150 non-demented subjects from a memory clinic. Forty two had progressed to Alzheimer type dementia during a five year follow up period and were considered to have predementia Alzheimer's disease at baseline. Outcome measures were the odds ratio, sensitivity, specificity, and positive and negative predictive value.

Results: The odds ratio of the MCI criteria for predementia Alzheimer's disease varied between 0.84 and 11. Sensitivity varied between 0.46 and 0.83 and positive predictive value between 0.43 and 0.76. None of the criteria combined a high sensitivity with a high positive predictive value. Exclusion criteria for depression led to an increase in positive predictive value and specificity at the cost of sensitivity. In subjects older than 65 years the positive predictive value was higher than in younger subjects.

Conclusions: The diagnostic accuracy of MCI criteria used in trials for predementia Alzheimer's disease is low to moderate. Their use may lead to inclusion of many patients who do not have predementia Alzheimer's disease or to exclusion of many who do. Subjects with moderately severe depression should not be excluded from trials in order not to reduce the sensitivity.

Full Text

The Full Text of this article is available as a PDF (81.1 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bennett D. A., Wilson R. S., Schneider J. A., Evans D. A., Beckett L. A., Aggarwal N. T., Barnes L. L., Fox J. H., Bach J. Natural history of mild cognitive impairment in older persons. Neurology. 2002 Jul 23;59(2):198–205. doi: 10.1212/wnl.59.2.198. [DOI] [PubMed] [Google Scholar]
  2. Berger A. K., Fratiglioni L., Forsell Y., Winblad B., Bäckman L. The occurrence of depressive symptoms in the preclinical phase of AD: a population-based study. Neurology. 1999 Dec 10;53(9):1998–2002. doi: 10.1212/wnl.53.9.1998. [DOI] [PubMed] [Google Scholar]
  3. Blessed G., Tomlinson B. E., Roth M. The association between quantitative measures of dementia and of senile change in the cerebral grey matter of elderly subjects. Br J Psychiatry. 1968 Jul;114(512):797–811. doi: 10.1192/bjp.114.512.797. [DOI] [PubMed] [Google Scholar]
  4. Feldman H., Scheltens P., Scarpini E., Hermann N., Mesenbrink P., Mancione L., Tekin S., Lane R., Ferris S. Behavioral symptoms in mild cognitive impairment. Neurology. 2004 Apr 13;62(7):1199–1201. doi: 10.1212/01.wnl.0000118301.92105.ee. [DOI] [PubMed] [Google Scholar]
  5. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  6. Grober E., Lipton R. B., Hall C., Crystal H. Memory impairment on free and cued selective reminding predicts dementia. Neurology. 2000 Feb 22;54(4):827–832. doi: 10.1212/wnl.54.4.827. [DOI] [PubMed] [Google Scholar]
  7. Grundman Michael, Petersen Ronald C., Ferris Steven H., Thomas Ronald G., Aisen Paul S., Bennett David A., Foster Norman L., Jack Clifford R., Jr, Galasko Douglas R., Doody Rachelle. Mild cognitive impairment can be distinguished from Alzheimer disease and normal aging for clinical trials. Arch Neurol. 2004 Jan;61(1):59–66. doi: 10.1001/archneur.61.1.59. [DOI] [PubMed] [Google Scholar]
  8. HAMILTON M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56–62. doi: 10.1136/jnnp.23.1.56. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hachinski V. C., Iliff L. D., Zilhka E., Du Boulay G. H., McAllister V. L., Marshall J., Russell R. W., Symon L. Cerebral blood flow in dementia. Arch Neurol. 1975 Sep;32(9):632–637. doi: 10.1001/archneur.1975.00490510088009. [DOI] [PubMed] [Google Scholar]
  10. Johnson Steven A., Simmon Vincent F. Randomized, double-blind, placebo-controlled international clinical trial of the Ampakine CX516 in elderly participants with mild cognitive impairment: a progress report. J Mol Neurosci. 2002 Aug-Oct;19(1-2):197–200. doi: 10.1007/s12031-002-0032-4. [DOI] [PubMed] [Google Scholar]
  11. Kluger A., Ferris S. H., Golomb J., Mittelman M. S., Reisberg B. Neuropsychological prediction of decline to dementia in nondemented elderly. J Geriatr Psychiatry Neurol. 1999 Winter;12(4):168–179. doi: 10.1177/089198879901200402. [DOI] [PubMed] [Google Scholar]
  12. Lines Christopher R., McCarroll Kathleen A., Lipton Richard B., Block Gilbert A., Prevention of Alzheimer's In Society's Elderly Study Group Telephone screening for amnestic mild cognitive impairment. Neurology. 2003 Jan 28;60(2):261–266. doi: 10.1212/01.wnl.0000042481.34899.13. [DOI] [PubMed] [Google Scholar]
  13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  14. Petersen Ronald C. Mild cognitive impairment clinical trials. Nat Rev Drug Discov. 2003 Aug;2(8):646–653. doi: 10.1038/nrd1155. [DOI] [PubMed] [Google Scholar]
  15. Reisberg B., Ferris S. H., de Leon M. J., Crook T. The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry. 1982 Sep;139(9):1136–1139. doi: 10.1176/ajp.139.9.1136. [DOI] [PubMed] [Google Scholar]
  16. Verhey F. R., Jolles J., Ponds R. W., Rozendaal N., Plugge L. A., de Vet R. C., Vreeling F. W., van der Lugt P. J. Diagnosing dementia: a comparison between a monodisciplinary and a multidisciplinary approach. J Neuropsychiatry Clin Neurosci. 1993 Winter;5(1):78–85. doi: 10.1176/jnp.5.1.78. [DOI] [PubMed] [Google Scholar]
  17. Visser P. J., Verhey F. R., Ponds R. W., Cruts M., Van Broeckhoven C. L., Jolles J. Course of objective memory impairment in non-demented subjects attending a memory clinic and predictors of outcome. Int J Geriatr Psychiatry. 2000 Apr;15(4):363–372. doi: 10.1002/(sici)1099-1166(200004)15:4<363::aid-gps129>3.0.co;2-4. [DOI] [PubMed] [Google Scholar]
  18. Visser P. J., Verhey F. R., Ponds R. W., Kester A., Jolles J. Distinction between preclinical Alzheimer's disease and depression. J Am Geriatr Soc. 2000 May;48(5):479–484. doi: 10.1111/j.1532-5415.2000.tb04992.x. [DOI] [PubMed] [Google Scholar]
  19. Visser Pieter Jelle, Verhey Frans R. J., Scheltens Philip, Cruts Marc, Ponds Rudolf W. H. M., Van Broeckhoven Christine L., Jolles Jellemer. Diagnostic accuracy of the Preclinical AD Scale (PAS) in cognitively mildly impaired subjects. J Neurol. 2002 Mar;249(3):312–319. doi: 10.1007/s004150200011. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES